Genmab — September 2019
-
God morgen.
-
En fantastisk dag i går.
-
Og til Pensionist....Der er INGEN panik at spore hverken fra Bulder eller mig. Vi er om nogen dem som år ud og år ind fastholder det lange sigte og har manet til ro i rækkerne, når aktien har taget sine ture i kælderen. Det har vi gjort her i chatten og jeg har gjort på flere finansmedier, ved foredrag og i analyser og artikler. https://play.borsen.dk/klip/5c6e15fd595ab4f00a32f2ee/helge_larsen_du_skal_have_is_i_maven_naar_du_er_genmab-aktionaer.html
-
Immuno-PET with Zr-daratumumab suggeshttps://twitter.com/malinhultcrantz/status/1172584843244384257?s=21
ted in a phase I study to be more sensitive than standard PET in detecting myeloma lesions -
-
-
Carfilzomihttps://twitter.com/myeloma_doc/status/1172710994575069185?s=21
b and Daratumumab Combination Proves Utility in CANDOR Study for Relapsed Myeloma Patients -
-
Poster JNJ-7564 GPRC5DxCD3
https://twitter.com/ChristieVerkle1/status/1172721173546725376/photo/1 -
JNJ- 7564 fra Genmab's hjemmeside.. http://www.genmab.com/product-pipeline/products-in-development/jnj-64407564
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind